Member Info for Borsaci06

TheoremRx agent: vcorp services llc
it raises funds, initiates clinical trails ...

vcorp services llc was acquired by Wolters Kluwer GRC in 2016
Wolters Kluwer
AMS: WKL = 102.35 eur, mcap:26.86b
ADRs U.S = 115.88 usd

generic COVID-19 Merck drug at about 50 cents a pill
https://www.reuters.com/business/healthcare-pharmaceuticals/indias-dr-reddys-launch-generic-covid-19-merck-pill-about-50-cents-2022-01-04/?taid=61d443acdf9b5d0001e2e01c&utm_campaign=trueAnthem:+Trending+Content&utm_medium=trueAnthem&utm_source=twitter

are we waiting for the above? like to know if it is the case. thanks

An agent for THEOREMRX, INC is VCORP SERVICES, LLC acquired by WOLTERS KLUWER

https://www.wolterskluwer.com/en/solutions/vcorp-services
AMS: WKL = 103.60 EUR
mcap = 26.78B EUR

https://twitter.com/wolters_kluwer?lang=en
https://twitter.com/vcorp_services?lang=en-GB
https://mobile.twitter.com/theoremrx

Dr. Dmitry Kats
The NiaCur Protocol
https://niacincurescovid.com/

hold4results,
based his covid19 protocol on Flush Niacin & updated it 3 times past few months. He says Niacin is a alien's gift to human

https://twitter.com/LovesCanada8/status/1455001274731094016

@BrianFeroldi
Want to know how I learned to become comfortable with huge price swings?
https://twitter.com/BrianFeroldi/status/1428361570489233410

India offers 75 oil and gas blocks in its largest-ever bid round for discovered fields
https://www.upstreamonline.com/exploration/india-offers-75-oil-and-gas-blocks-in-its-largest-ever-bid-round-for-discovered-fields/2-1-1132488

" During proteolysis of the protein, a bioactive peptide, called lactoferricin can be released, that has more potent antimicrobial activity than the intact protein. This peptide contains two essential Trp residues and several Arg residues, and short synthetic hexapeptides and peptidomimetics can emulate this microbicidal effect.

Moreover we will show that such lactoferrin-inspired peptides can also display an antitumour effect."

Clearly, lactoferrin can contribute in multiple ways to host defence.
Professor Tomoyasu Aizawa
Faculty of Advanced Life Science

0.14 pence (0.259 AUD cents) per share (Placement)

@JavierBlas
The combination of cold weather and lack of wind is forcing Europe to rely more on fossil fuels for power, which in turn is pushing up the cost of CO2 to a record high (above €83 per tonne today).
In the UK, the grid is relying on fossil fuels for >60% of generation this morning
https://twitter.com/JavierBlas/status/1468141173386715136

Japanese Pharma,

Japan population
2010: 127 million
2015: 126 million
2020: 125 million
https://twitter.com/spectatorindex/status/1467886554500632579

@EthicalSkeptic
50 mutation genetic difference dictates 10.3 total years of genetic distance (by well-vetted rates of mutation) from Omicron to Alpha. Apportioned by mutations/arrival time, this places LCA of Alpha-Omicron in April of 2016.

@EthicalSkeptic
Replying to @snackalittle and @DrKellyVictory
Omicron has old genetics. Older than Wuhan Dec 2019... so, we have a problem.

@drakchaurasia
means B.1.1.529 was in existence in bat before 2019 in some bat?
now, same evolved from base coV2 by selective mutations?

@BidoliNicola
Replying to @drakchaurasia @EthicalSkeptic and 2 others
Yes, correct; or rather its "involuted" (incomplete) sequence which, through some portions of the sequence belonging to the Delta variant, suddenly reappeared (re-emerged in complete form).

@drakchaurasia
and, possessing phenotypes, nearby delta?
is there any mean to assess it's virulence from genomic study? comparing it with alfa or kappa?

@EthicalSkeptic
Replying to @drakchaurasia @BidoliNicola and 2 others
Not in a bat - in humans in 2018/19.

https://twitter.com/EthicalSkeptic/status/1466902747773607946

?????????????? ???????? = January 2018

@EthicalSkeptic
Dec 5
OK, through examining the latest Omicron sequence sample QLD-2568 from 2 Dec 2021, & using a well vetted rate of sustained mutation - parsing this genetic distance into the lineages of Alpha and Omicron - I get a divergence (Last Common Ancestor) date of
?????????????? ????????

@ClownBasket
Replying to @EthicalSkeptic
But hosts are needed to get from the common ancestor LCA to Alpha & Omicron. Does this mean that there was no “leak” in Dec 19 but just an announcement of a leak? That both alpha & omicron were already in the population since 2018?

@EthicalSkeptic
Replying to @ClownBasket
Co-rekt
https://twitter.com/EthicalSkeptic/status/1467365370394722304

wonder if bc201 targets any of these mutations on sarscov2 - omicron
https://twitter.com/davidrliu/status/1464714206150807559/photo/1

" The vaccine is inhaled through the mouth into the respiratory tract and lungs to stimulate mucosal immunity that can't be created by intramuscular injections. "
https://news.cgtn.com/news/2021-11-13/World-s-first-inhaled-COVID-19-vaccine-unveiled-159rlyUJn0c/index.html

" Aerosolized inhalable Ad5-nCoV vaccine requires only one-fifth of the dosage of an injected one "
https://www.republicworld.com/world-news/china/china-launches-covid-19-vaccine-that-can-be-inhaled-through-mouth-report.html

LEAKED DOCUMENT shows that Germany has already plans in place for up to SIX total doses!
https://twitter.com/USMortality/status/1460327221508329480

RKI has been preparing the 6th VACCINATION and state of emergency until the end of 2023 since the beginning of September
https://zachariasfoegen.wordpress.com/2021/11/15/rki-bereitet-6-impfung-vor/

@gerdosi
Wow, early robust IFN response makes adaptive immunity almost obsolete in SARS2 infection.

“In immunodeficient mice carrying chronic SARS-CoV-2 infection, SLR14 elicited near-sterilizing innate immunity in the absence of the adaptive immune system.”

https://news.yale.edu/2021/11/10/immune-system-early-responder-can-combat-covid-19
" The molecule, known as SLR14, is a simple, easy to manufacture, loop of RNA that can trigger the production of interferons, a group of proteins produced by immune cells that are key to the body’s innate, or initial, response to infection.
Multiple studies have shown that COVID-19 patients who produce high levels of interferons have far better outcomes than those for whom interferon levels are low during early days of infection. "

“SLR14 therefore holds great promise as a new class of RNA therapeutics that can be applied as antivirals against SARS-CoV-2,” said Akiko Iwasaki, the Waldemar Von Zedtwitz Professor of Immunobiology and Molecular, Cellular, and Developmental Biology at Yale and corresponding author of the paper.
“Moreover, because this RNA-based therapeutic approach is simple and versatile, our study will facilitate pandemic preparedness and response against future respiratory pathogens sensitive to Type I interferons.”

European Pharmaceutical Review
@PharmaReview
The European Medicines Agency’s human medicines committee (CHMP) has recommended authorising Ronapreve and Regkirona for COVID-19.
https://twitter.com/PharmaReview/status/1459136419490840599